Interleukin-2 and granulocyte–macrophage–colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer-Reference-Cited by-同舟云学术

Interleukin-2 and granulocyte–macrophage–colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

Published:2009-12 Issue:5 Volume:90 Page:627-634
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Cheng Yee Chung,Rondón Gabriela,Sanchez Leah F.,McMannis John D.,Couriel Daniel R.,de Lima Marcos J.,Hosing Chitra,Khouri Issa F.,Giralt Sergio A.,Champlin Richard E.,Ueno Naoto T.

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-009-0439-6.pdf

Reference44 articles.

1. Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK, Buzdar AU. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol. 1996;14:2197–205.

2. Eder JP, Antman K, Peters W, Henner WD, Elias A, Shea T, et al. High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer. J Clin Oncol. 1986;4:1592–7.

3. Peters WP, Shpall EJ, Jones RB, Olsen GA, Bast RC, Gockerman JP, et al. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol. 1988;6:1368–76.

4. Williams SF, Mick R, Desser R, Golick J, Beschorner J, Bitran JD. High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer. J Clin Oncol. 1989;7:1824–30.

5. Kennedy MJ, Beveridge RA, Rowley SD, Gordon GB, Abeloff MD, Davidson NE. High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer. J Natl Cancer Inst. 1991;83:920–6.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumour growth and immune evasion as targets for a new strategy in advanced cancer;Endocrine-Related Cancer;2018-11

2. Biomarkers and the ‘target therapies’ in oncology, research and business;Biomarkers in Medicine;2017-03

3. Immunotherapy and Hormone-therapy in Metastatic Breast Cancer: A Review and an Update;Current Drug Targets;2016-06-24

4. Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry;Bone Marrow Transplantation;2012-08-06

5. Is High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Breast Cancer Patients a Done Deal?;Women's Health;2010-07